Prebiotic fiber as adjunct to peanut oral immunotherapy in children

Phase 2, randomised, double-blind trial in peanut allergy, sponsored by University of Chicago. Primary endpoint: Proportion of subjects mildly symptomatic or less at the 12 month double-blind placebo-controlled food challenge. Started Nov 2021; status: completed.